Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coronavirus (SARS-CoV)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07224490
What this trial is testing

Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease

Who this might be right for
Reproductive DisorderNeurodegenerationSARS-CoV 2+1 more
Stephanie B. Seminara, MD 40
Very early researchLooking for participantsNCT05656105
What this trial is testing

Positron Emission Tomography (PET) Imaging of Neuroinflammation in Patients With Neurological Dysfunction After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2) Infection

Who this might be right for
SARS CoV-2 Post-Acute Sequelae
University of Alabama at Birmingham 60
Testing effectiveness (Phase 2)WithdrawnNCT06997653
What this trial is testing

Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) in Healthy Pregnant Women

Who this might be right for
COVID-19SARS CoV 2 Infection
Health Institutes of Turkey
Not applicableStudy completedNCT04758039
What this trial is testing

Clinical Characteristics and In-hospital Death of a Chilean COVID-19 Prospective Cohort

Who this might be right for
Corona Virus Infection
University of Chile 395
Large-scale testing (Phase 3)Study completedNCT04864561
What this trial is testing

COV-COMPARE Immunogenicity of Vaccine VLA2001 Compared to AZD1222

Who this might be right for
SARS-CoV-2 Virus Infection
Valneva Austria GmbH 4,034
Not applicableUnknownNCT04402814
What this trial is testing

IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing.

Who this might be right for
SARS-CoV 2
Fadi Haddad, M.D. 90
Large-scale testing (Phase 3)Ended earlyNCT04730206
What this trial is testing

The DAWN Antivirals Trial for Ambulatory COVID-19 Patients

Who this might be right for
Covid19SARS-CoV Infection
KU Leuven 44
Post-approval studies (Phase 4)WithdrawnNCT04334629
What this trial is testing

LIBERATE Trial in COVID-19

Who this might be right for
CoronavirusRespiratory Distress SyndromeSARS-CoV Infection
King's College London
Testing effectiveness (Phase 2)Study completedNCT06234956
What this trial is testing

Open-label, Multi-centre, Non-Inferiority Study of Safety and Immunogenicity of BIMERVAX for the Prevention of COVID-19 in Adolescents From 12 Years to Less Than 18 Years of Age.

Who this might be right for
SARS CoV 2 Infection
Hipra Scientific, S.L.U 242
Not applicableUnknownNCT04383483
What this trial is testing

CoV-ICU Score, Intensive Care Unit, SARS-CoV-2

Who this might be right for
Coronavirus as the Cause of Diseases Classified Elsewhere
Bursa Yuksek Ihtisas Training and Research Hospital 100
Not applicableEnrolling By InvitationNCT04705766
What this trial is testing

KIDney Injury in Times of COVID-19 (KIDCOV)

Who this might be right for
SARS-CoV InfectionCovid19Corona Virus Infection+2 more
University of California, San Francisco 2,000
Not applicableUnknownNCT04548505
What this trial is testing

Recovery of Exertion Ability Following COVID-19 Infection in Military Staff

Who this might be right for
SARS-CoV Infection
Direction Centrale du Service de Santé des Armées 100
Testing effectiveness (Phase 2)Ended earlyNCT04459286
What this trial is testing

The Nitazoxanide Plus Atazanavir for COVID-19 Study

Who this might be right for
Covid-19
Obafemi Awolowo University 57
Testing effectiveness (Phase 2)Study completedNCT04399980
What this trial is testing

Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation

Who this might be right for
COVID 19SARS-CoV 2Pneumonia
The Cleveland Clinic 40
Not applicableEnrolling By InvitationNCT06401720
What this trial is testing

Age Related Differences in Respiratory Immune Responses in Influenza Virus Infection

Who this might be right for
Influenza A InfectionInfluenza B Virus InfectionSARS CoV 2 Infection+1 more
Karolinska Institutet 800
Not applicableStudy completedNCT05063812
What this trial is testing

Performance of a Remote Monitoring Program for Patients Diagnosed With COVID-19

Who this might be right for
Covid19Infectious DiseaseSARS-CoV Infection
George Washington University 18
Not applicableWithdrawnNCT04405362
What this trial is testing

Consequences of the QUARANTINE Relating to the COvid-19 Epidemic on the Mental Health of the Patients Followed in PSYchiatry

Who this might be right for
SARS-CoV 2Traumatic Stress Disorder
University Hospital, Lille
Not applicableEnded earlyNCT04322279
What this trial is testing

Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID-19.

Who this might be right for
Coronavirus
Institut National de la Santé Et de la Recherche Médicale, France 81
Post-approval studies (Phase 4)Study completedNCT04340557
What this trial is testing

Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection

Who this might be right for
SARS-CoV Infection
Sharp HealthCare 31
Not applicableEnded earlyNCT04566965
What this trial is testing

Serology to COVID-19 for Recording Exposures and Evaluating Needs

Who this might be right for
Covid19CoronavirusSARS-CoV Infection
Children's Hospital Medical Center, Cincinnati 232
Next Page